nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—renal system—cervical cancer	0.032	0.0321	CbGeAlD
L-Carnitine—SLC22A16—female reproductive system—cervical cancer	0.0256	0.0257	CbGeAlD
L-Carnitine—CROT—uterine cervix—cervical cancer	0.0247	0.0248	CbGeAlD
L-Carnitine—SLC25A29—endometrium—cervical cancer	0.0244	0.0245	CbGeAlD
L-Carnitine—CROT—decidua—cervical cancer	0.0236	0.0237	CbGeAlD
L-Carnitine—CROT—mammalian vulva—cervical cancer	0.0216	0.0217	CbGeAlD
L-Carnitine—SLC25A20—uterine cervix—cervical cancer	0.0215	0.0216	CbGeAlD
L-Carnitine—CRAT—uterine cervix—cervical cancer	0.0209	0.021	CbGeAlD
L-Carnitine—CROT—uterus—cervical cancer	0.0206	0.0207	CbGeAlD
L-Carnitine—SLC25A20—decidua—cervical cancer	0.0205	0.0206	CbGeAlD
L-Carnitine—SLC25A29—female reproductive system—cervical cancer	0.0202	0.0203	CbGeAlD
L-Carnitine—SLC25A20—renal system—cervical cancer	0.0201	0.0202	CbGeAlD
L-Carnitine—CRAT—decidua—cervical cancer	0.0199	0.02	CbGeAlD
L-Carnitine—CRAT—renal system—cervical cancer	0.0195	0.0196	CbGeAlD
L-Carnitine—SLC25A20—endometrium—cervical cancer	0.0195	0.0195	CbGeAlD
L-Carnitine—CRAT—endometrium—cervical cancer	0.0189	0.019	CbGeAlD
L-Carnitine—SLC25A20—mammalian vulva—cervical cancer	0.0188	0.0189	CbGeAlD
L-Carnitine—CROT—female reproductive system—cervical cancer	0.0185	0.0186	CbGeAlD
L-Carnitine—SLC25A29—female gonad—cervical cancer	0.0184	0.0185	CbGeAlD
L-Carnitine—CRAT—mammalian vulva—cervical cancer	0.0183	0.0183	CbGeAlD
L-Carnitine—SLC25A20—uterus—cervical cancer	0.0179	0.018	CbGeAlD
L-Carnitine—CRAT—uterus—cervical cancer	0.0174	0.0175	CbGeAlD
L-Carnitine—CROT—female gonad—cervical cancer	0.0169	0.0169	CbGeAlD
L-Carnitine—CROT—vagina—cervical cancer	0.0168	0.0168	CbGeAlD
L-Carnitine—SLC25A20—female reproductive system—cervical cancer	0.0161	0.0162	CbGeAlD
L-Carnitine—CPT2—uterine cervix—cervical cancer	0.0161	0.0161	CbGeAlD
L-Carnitine—CPT1A—renal system—cervical cancer	0.0158	0.0159	CbGeAlD
L-Carnitine—CRAT—female reproductive system—cervical cancer	0.0156	0.0157	CbGeAlD
L-Carnitine—CPT2—decidua—cervical cancer	0.0153	0.0154	CbGeAlD
L-Carnitine—CPT2—renal system—cervical cancer	0.015	0.0151	CbGeAlD
L-Carnitine—SLC25A20—female gonad—cervical cancer	0.0147	0.0147	CbGeAlD
L-Carnitine—SLC25A20—vagina—cervical cancer	0.0146	0.0146	CbGeAlD
L-Carnitine—CPT2—endometrium—cervical cancer	0.0145	0.0146	CbGeAlD
L-Carnitine—CRAT—female gonad—cervical cancer	0.0142	0.0143	CbGeAlD
L-Carnitine—CRAT—vagina—cervical cancer	0.0141	0.0142	CbGeAlD
L-Carnitine—CPT2—mammalian vulva—cervical cancer	0.014	0.0141	CbGeAlD
L-Carnitine—CPT2—uterus—cervical cancer	0.0134	0.0134	CbGeAlD
L-Carnitine—CPT1A—female reproductive system—cervical cancer	0.0127	0.0127	CbGeAlD
L-Carnitine—XDH—uterine cervix—cervical cancer	0.0125	0.0126	CbGeAlD
L-Carnitine—CPT2—female reproductive system—cervical cancer	0.012	0.0121	CbGeAlD
L-Carnitine—SLC25A29—lymph node—cervical cancer	0.0118	0.0119	CbGeAlD
L-Carnitine—XDH—renal system—cervical cancer	0.0117	0.0117	CbGeAlD
L-Carnitine—CPT1A—female gonad—cervical cancer	0.0115	0.0116	CbGeAlD
L-Carnitine—CPT1A—vagina—cervical cancer	0.0115	0.0115	CbGeAlD
L-Carnitine—XDH—endometrium—cervical cancer	0.0113	0.0114	CbGeAlD
L-Carnitine—CPT2—female gonad—cervical cancer	0.0109	0.011	CbGeAlD
L-Carnitine—XDH—mammalian vulva—cervical cancer	0.0109	0.011	CbGeAlD
L-Carnitine—CPT2—vagina—cervical cancer	0.0109	0.0109	CbGeAlD
L-Carnitine—CROT—lymph node—cervical cancer	0.0108	0.0109	CbGeAlD
L-Carnitine—SLC25A20—lymph node—cervical cancer	0.00943	0.00947	CbGeAlD
L-Carnitine—XDH—female reproductive system—cervical cancer	0.00937	0.00941	CbGeAlD
L-Carnitine—CRAT—lymph node—cervical cancer	0.00915	0.00919	CbGeAlD
L-Carnitine—XDH—vagina—cervical cancer	0.00847	0.00851	CbGeAlD
L-Carnitine—MPO—epithelium—cervical cancer	0.00803	0.00807	CbGeAlD
L-Carnitine—SLCO1B1—renal system—cervical cancer	0.00766	0.0077	CbGeAlD
L-Carnitine—MPO—renal system—cervical cancer	0.00745	0.00748	CbGeAlD
L-Carnitine—CPT1A—lymph node—cervical cancer	0.00741	0.00745	CbGeAlD
L-Carnitine—CES1—female reproductive system—cervical cancer	0.00714	0.00718	CbGeAlD
L-Carnitine—CPT2—lymph node—cervical cancer	0.00703	0.00707	CbGeAlD
L-Carnitine—SLC22A4—decidua—cervical cancer	0.00693	0.00696	CbGeAlD
L-Carnitine—SLC22A4—renal system—cervical cancer	0.0068	0.00683	CbGeAlD
L-Carnitine—SLC22A4—endometrium—cervical cancer	0.00657	0.00661	CbGeAlD
L-Carnitine—CES1—female gonad—cervical cancer	0.0065	0.00653	CbGeAlD
L-Carnitine—SLCO1B1—female reproductive system—cervical cancer	0.00614	0.00616	CbGeAlD
L-Carnitine—SLC22A8—renal system—cervical cancer	0.00595	0.00598	CbGeAlD
L-Carnitine—SLC22A4—female reproductive system—cervical cancer	0.00545	0.00547	CbGeAlD
L-Carnitine—SLC22A4—vagina—cervical cancer	0.00493	0.00495	CbGeAlD
L-Carnitine—SLC22A5—uterine cervix—cervical cancer	0.00481	0.00483	CbGeAlD
L-Carnitine—SLC22A5—renal system—cervical cancer	0.0045	0.00452	CbGeAlD
L-Carnitine—SLC22A5—endometrium—cervical cancer	0.00435	0.00437	CbGeAlD
L-Carnitine—CES1—lymph node—cervical cancer	0.00418	0.0042	CbGeAlD
L-Carnitine—SLC22A5—female reproductive system—cervical cancer	0.0036	0.00362	CbGeAlD
L-Carnitine—MPO—lymph node—cervical cancer	0.00349	0.00351	CbGeAlD
L-Carnitine—SLC22A5—female gonad—cervical cancer	0.00328	0.00329	CbGeAlD
L-Carnitine—SLC22A5—vagina—cervical cancer	0.00326	0.00327	CbGeAlD
L-Carnitine—SLC22A4—lymph node—cervical cancer	0.00319	0.0032	CbGeAlD
L-Carnitine—SLC22A5—lymph node—cervical cancer	0.00211	0.00212	CbGeAlD
L-Carnitine—Weight increased—Topotecan—cervical cancer	0.000225	0.0483	CcSEcCtD
L-Carnitine—Haemoglobin—Topotecan—cervical cancer	0.000199	0.0427	CcSEcCtD
L-Carnitine—Rhinitis—Topotecan—cervical cancer	0.000199	0.0426	CcSEcCtD
L-Carnitine—Haemorrhage—Topotecan—cervical cancer	0.000198	0.0425	CcSEcCtD
L-Carnitine—Pharyngitis—Topotecan—cervical cancer	0.000197	0.0421	CcSEcCtD
L-Carnitine—Angiopathy—Topotecan—cervical cancer	0.00018	0.0385	CcSEcCtD
L-Carnitine—Back pain—Topotecan—cervical cancer	0.000167	0.0357	CcSEcCtD
L-Carnitine—Muscle spasms—Topotecan—cervical cancer	0.000166	0.0355	CcSEcCtD
L-Carnitine—Anaemia—Topotecan—cervical cancer	0.00016	0.0342	CcSEcCtD
L-Carnitine—Cough—Topotecan—cervical cancer	0.000151	0.0322	CcSEcCtD
L-Carnitine—Myalgia—Topotecan—cervical cancer	0.000147	0.0315	CcSEcCtD
L-Carnitine—Chest pain—Topotecan—cervical cancer	0.000147	0.0315	CcSEcCtD
L-Carnitine—Infection—Topotecan—cervical cancer	0.00014	0.03	CcSEcCtD
L-Carnitine—Anorexia—Topotecan—cervical cancer	0.000134	0.0287	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000128	0.0275	CcSEcCtD
L-Carnitine—Paraesthesia—Topotecan—cervical cancer	0.000126	0.0271	CcSEcCtD
L-Carnitine—Dyspnoea—Topotecan—cervical cancer	0.000126	0.0269	CcSEcCtD
L-Carnitine—Dyspepsia—Topotecan—cervical cancer	0.000124	0.0265	CcSEcCtD
L-Carnitine—Decreased appetite—Topotecan—cervical cancer	0.000122	0.0262	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Topotecan—cervical cancer	0.000122	0.026	CcSEcCtD
L-Carnitine—Constipation—Topotecan—cervical cancer	0.00012	0.0258	CcSEcCtD
L-Carnitine—Pain—Topotecan—cervical cancer	0.00012	0.0258	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Topotecan—cervical cancer	0.000115	0.0247	CcSEcCtD
L-Carnitine—Abdominal pain—Topotecan—cervical cancer	0.000111	0.0238	CcSEcCtD
L-Carnitine—Body temperature increased—Topotecan—cervical cancer	0.000111	0.0238	CcSEcCtD
L-Carnitine—Hypersensitivity—Topotecan—cervical cancer	0.000104	0.0222	CcSEcCtD
L-Carnitine—Asthenia—Topotecan—cervical cancer	0.000101	0.0216	CcSEcCtD
L-Carnitine—Pruritus—Topotecan—cervical cancer	9.96e-05	0.0213	CcSEcCtD
L-Carnitine—Diarrhoea—Topotecan—cervical cancer	9.64e-05	0.0206	CcSEcCtD
L-Carnitine—Dizziness—Topotecan—cervical cancer	9.31e-05	0.0199	CcSEcCtD
L-Carnitine—Vomiting—Topotecan—cervical cancer	8.96e-05	0.0192	CcSEcCtD
L-Carnitine—Rash—Topotecan—cervical cancer	8.88e-05	0.019	CcSEcCtD
L-Carnitine—Dermatitis—Topotecan—cervical cancer	8.87e-05	0.019	CcSEcCtD
L-Carnitine—Headache—Topotecan—cervical cancer	8.82e-05	0.0189	CcSEcCtD
L-Carnitine—Nausea—Topotecan—cervical cancer	8.37e-05	0.0179	CcSEcCtD
